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The cardiovascular health of those infected with severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) plays a major role in rates of hospitalization, mortality risk, and rates of mechanical 
ventilation. In patients with COVID-19, acute myocardial injury and history of cardiovascular disease are 
both independently established risk factors for poor patient prognosis. In addition to myocardial injury, 
numerous acute cardiovascular manifestations of COVID-19 disease have been identified. Previous work 
on this topic typically focused either upon a general description of the acute cardiovascular 
manifestations and sequalae of COVID-19, or upon broad-based clinical outcomes associated with 
COVID-19 in patients with history of cardiovascular and/or metabolic disease. However, the role of pre-
existing cardiovascular and metabolic disease in predicting the development and severity of COVID-19-
related cardiovascular complications remains unclear. We queried our institutional COVID-19 patient 
registry, extracting data on all patients who were tested for the presence of SARS-CoV-2 and myocardial 
injury from 3 March 2020 – 30 July 2020. We identified a total of 5,451 patients from our institutional 
COVID-19 registry who met our criteria, including 734 (13.5%) subjects ultimately confirmed to be 
COVID-19 positive, and 4,717 subjects confirmed to be COVID-19 negative. Those with a prior history of 
cardiovascular disease can have increased frequency of cardiovascular manifestations. Cardiovascular 
events in COVID-19 include acute myocardial injury, myocardial infarction, myocarditis, pericarditis, 
electrocardiogram abnormalities, acute thrombosis, and acute heart failure. Identifying underlying 
cardiovascular disease and evidence of myocardial injury may predict which patients should be 
prioritized or potentially require more aggressive management and treatment strategies.   
 
Keywords: COVID-19, SARS-CoV-2, myocardial infarction, myocardial injury, cardiomyopathy, 
cardiovascular 
